Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

We are delighted to announce that in recognition of the alliance between Oxford University and University College London, the Centre for the Acceleration of Medical Innovation (CAMI) is being renamed CASMI, the Centre for the Advancement of Sustainable Medical Innovation.

2012-12-05 CASMICASMI’s board will now be chaired jointly by Sir John Bell of Oxford and Sir John Tooke of UCL. This unique venture not only offers the Centre the support, infrastructure and international reputation of both institutions but also maximises engagement with academics at the forefront of their fields.

CASMI aims to address the issues that have lead to current failures in the translation of basic bioscience into affordable and widely adopted new treatments.

CASMI will continue the work on Adaptive Licensing (a new approach to enabling earlier access for patients to new medicines), the regulation of cell therapy and the future environment for stratified medicine. In 2013 we plan to extend into other key areas central to the effective generation, development, regulation and adoption of innovative medical technologies, and we welcome dialogue with supporters and collaborators on this future agenda.

See more on the CASMI website

Similar stories

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.

Three NHSBT research units launch at University of Oxford

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford.

Fourth COVID-19 vaccine dose provides stronger immunity boost than third dose, shows UK study

COVID-19 vaccines given as fourth doses in the UK offer excellent boosting immunity protection, according to the latest results from a nationwide NIHR-supported study.

COVID-19’s high blood clot risk

A recent study of patient health records found that around 1 in 100 people with COVID-19 had a venal or arterial thrombosis, with rates higher still among males, and particularly for those hospitalised.

Medical Sciences Division receives REF 2021 results

Today the UK Funding Bodies have published the outcomes of the recent national research assessment exercise, the Research Excellence Framework (REF) 2021. REF is the UK-wide assessment of research in universities, and provides an expert evaluation of the quality of the research outputs, impact and environment at subject level in each university.